RxDoctor Payments Data

Jared Henderson, MD

Family Medicine · Twin Falls, IDNPI 1336597152

Payments from drug & device makers

$700in general payments, 2019–2025

Across 34 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$159
  • Novartis$79
  • Exact Sciences$76
  • AbbVie$50
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$38
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$35
  • plus $262 from 12 others

What the payments were for

  • Food & beverage$700100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$700 in reported general payments places this provider in the 65th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$60,299
Medicare patients
148
Services billed
968

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide141$158,706
JardianceEmpagliflozin68$81,447
EliquisApixaban79$70,181
TrulicityDulaglutide55$55,790
XareltoRivaroxaban43$40,632
MounjaroTirzepatide34$34,035
Repatha SureclickEvolocumab19$11,453
MyrbetriqMirabegron11$9,774
Bydureon BciseExenatide Microspheres12$9,694
Spiriva RespimatTiotropium Bromide12$8,528
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl29$7,838
Duloxetine Hcl114$3,673
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$3,585
Varenicline Tartrate12$3,079
Atorvastatin Calcium343$2,979

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$159$158,706141 claims
PfizerEliquis$23$70,18179 claims
Johnson & JohnsonXarelto$18$40,63243 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 803 family medicine providers in Idaho.

Other family medicine in Twin Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →